Circulating tumor DNA analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III colon cancer

J Tie, JD Cohen, Y Wang, M Christie, K Simons… - JAMA …, 2019 - jamanetwork.com
Importance Adjuvant chemotherapy in patients with stage III colon cancer prevents
recurrence by eradicating minimal residual disease. However, which patients remain at high …
被引用次数：493 相关文章

Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer

J Tie, JD Cohen, Y Wang, M Christie… - JAMA …, 2019 - research.monash.edu
Importance: Adjuvant chemotherapy in patients with stage III colon cancer prevents
recurrence by eradicating minimal residual disease. However, which patients remain at high …

Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer

J Tie, JD Cohen, Y Wang, M Christie… - JAMA …, 2019 - pubmed.ncbi.nlm.nih.gov
Importance Adjuvant chemotherapy in patients with stage III colon cancer prevents
recurrence by eradicating minimal residual disease. However, which patients remain at high …

Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer.

J Tie, JD Cohen, Y Wang, M Christie, K Simons… - JAMA …, 2019 - europepmc.org
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy
for Stage III Colon Cancer. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …
[HTML] nih.gov

[HTML][HTML] Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer

J Tie, JD Cohen, Y Wang, M Christie, K Simons… - JAMA …, 2019 - ncbi.nlm.nih.gov
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant
Therapy for Stage III Colon Cancer - PMC Back to Top Skip to main content NIH NLM Logo …
[PDF] jamanetwork.com

[PDF][PDF] Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer

J Tie, JD Cohen, Y Wang, M Christie, K Simons… - JAMA …, 2019 - jamanetwork.com
Importance Adjuvant chemotherapy in patients with stage III colon cancer prevents
recurrence by eradicating minimal residual disease. However, which patients remain at high …

Circulating tumor dna analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III colon cancer

J Tie, JD Cohen, Y Wang, M Christie… - JAMA …, 2019 - pure.johnshopkins.edu
Importance: Adjuvant chemotherapy in patients with stage III colon cancer prevents
recurrence by eradicating minimal residual disease. However, which patients remain at high …

[引用][C] Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer

J Tie, JD Cohen, Y Wang, M Christie, K Simons, M Lee… - JAMA Oncology, 2019 - cir.nii.ac.jp
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant
Therapy for Stage III Colon Cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁 …

Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer.

J Tie, JD Cohen, Y Wang, M Christie, K Simons… - JAMA …, 2019 - europepmc.org
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy
for Stage III Colon Cancer. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …